Assertio Holdings, Inc. (ASRT)
19.88
+0.82
(+4.30%)
USD |
NASDAQ |
Apr 01, 16:00
19.88
0.00 (0.00%)
Pre-Market: 08:33
Assertio Holdings Research and Development Expense (TTM) : 1.69M for Dec. 31, 2025
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Castle Biosciences, Inc. | 51.50M |
| ANI Pharmaceuticals, Inc. | 51.66M |
| Alkermes Plc | 318.36M |
| Catalyst Pharmaceuticals, Inc. | 12.71M |
| Aura Biosciences, Inc. | 90.30M |